Cilian AG is an innovative German biotechnology company based in Munster that uses ciliates as a novel class of production organisms for industrial protein production. The company has collaborated on recombinant influenza vaccines and received investment from Lonza, operating as a platform technology company rather than a contract drug manufacturer.
Ciliate-based protein expression, recombinant protein production, vaccine development platform
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.